Search Results - "Crippa, Stefania"

An early‐senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro‐inflammatory program.

Authors: Gnani, Daniela Crippa, Stefania della Volpe, Lucrezia et al.

Source: Aging Cell. Jun2019, Vol. 18 Issue 3, p1-21. 21p.

This result is not displayed to guests.
Login for full access.

Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity.

Authors: Crippa, Stefania Rossella, Valeria Aprile, Annamaria et al.

Source: Journal of Clinical Investigation. Apr2019, Vol. 129 Issue 4, p1566-1580. 15p.

Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders.

Authors: Crippa, Stefania Santi, Ludovica Bosotti, Roberto et al.

Source: Journal of Clinical Medicine. Jan2020, Vol. 9 Issue 1, p2-2. 1p.

Comparative transcriptome profiling of the injured zebrafish and mouse hearts identifies miRNA-dependent repair pathways.

Authors: Crippa, Stefania Nemir, Mohamed Ounzain, Samir et al.

Source: Cardiovascular Research. May2016, Vol. 110 Issue 1, p73-84. 12p.

Small and long non-coding RNAs in cardiac homeostasis and regeneration

Authors: Ounzain, Samir Crippa, Stefania Pedrazzini, Thierry

Source: BBA - Molecular Cell Research. Apr2013, Vol. 1833 Issue 4, p923-933. 11p.

This result is not displayed to guests.
Login for full access.

Human Bone Marrow-Derived Mesenchymal Stromal Cells Reduce the Severity of Experimental Necrotizing Enterocolitis in a Concentration-Dependent Manner.

Authors: Provitera, Livia Tomaselli, Andrea Raffaeli, Genny et al.

Source: Cells (2073-4409). Mar2023, Vol. 12 Issue 5, p760. 17p.

Guide Cells Support Muscle Regeneration and Affect Neuro-Muscular Junction Organization.

Authors: Ronzoni, Flavio L. Giarratana, Nefele Crippa, Stefania et al.

Source: International Journal of Molecular Sciences. Feb2021, Vol. 22 Issue 4, p1939-1939. 1p.

Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.

Authors: Reichardt, Peter Schlemmer, Marcus Delgado Perez, Juan R. et al.

Source: Oncology Research & Treatment. Dec2019, Vol. 42 Issue 12, p629-635. 7p.

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Authors: Fogarasi, Andras De Waele, Liesbeth Bartalini, Gabriella et al.

Source: BMC Neurology. 8/8/2016, Vol. 16, p1-9. 9p. 6 Charts, 1 Graph.

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential.

Authors: Santi, Ludovica Beretta, Stefano Berti, Margherita et al.

Source: BBA - Molecular Cell Research. Dec2024, Vol. 1871 Issue 8, pN.PAG-N.PAG. 1p.

3117 – HSCS IN Β-THALASSEMIA HAVE A REDUCED DORMANCY AND AN ERYTHROID BIASED LINEAGE COMMITMENT IN RESPONSE TO ALTERED TGFΒ SIGNALING IN THE BM MICROENVIRONMENT.

Authors: Lidonnici, Maria Rosa Chianella, Giulia Mende, Nicole et al.

Source: Experimental Hematology. 2024 Supplement, Vol. 137, pN.PAG-N.PAG. 1p.

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.

Authors: Joensuu, Heikki Blay, Jean-Yves Comandone, Alessandro et al.

Source: British Journal of Cancer. 10/24/2017, Vol. 117 Issue 9, p1278-1285. 8p. 3 Charts, 3 Graphs.

TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.

Authors: Kingswood, John C Bruzzi, Paolo Curatolo, Paolo et al.

Source: Orphanet Journal of Rare Diseases. 2014, Vol. 9 Issue 1, p182-190. 9p. 3 Diagrams, 2 Charts, 1 Map.

Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency.

Authors: Gálvez, Beatriz G. Covarello, Diego Tolorenzi, Rosanna et al.

Source: Cardiovascular Research. Sep2009, Vol. 83 Issue 4, p707-716. 10p. 4 Color Photographs, 3 Charts, 3 Graphs.

Bone marrow-derived mesenchymal stromal cells in necrotizing enterocolitis treatment: a narrative review.

Authors: Tomaselli A Tripodi M Provitera L et al.

Source: Frontiers in pediatrics [Front Pediatr] 2025 Jul 31; Vol. 13, pp. 1624236. Date of Electronic Publication: 2025 Jul 31 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101615492 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2360 (Print) Linking ISSN: 22962360 NLM ISO Abbreviation: Front Pediatr Subsets: PubMed not MEDLINE

Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia.

Authors: Lidonnici MR Chianella G Mende N et al.

Source: Nature communications [Nat Commun] 2025 Jul 01; Vol. 16 (1), pp. 5639. Date of Electronic Publication: 2025 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease.

Authors: Berti M Ceriotti S Santi L et al.

Source: Disease models & mechanisms [Dis Model Mech] 2026 Feb 01; Vol. 19 (2). Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Company of Biologists Ltd Country of Publication: England NLM ID: 101483332 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-8411 (Electronic) Linking ISSN: 17548403 NLM ISO Abbreviation: Dis Model Mech Subsets: MEDLINE

Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I.

Authors: De Ponti G Santi L Dina G et al.

Source: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2025 Jul 30; Vol. 33 (3), pp. 101544. Date of Electronic Publication: 2025 Jul 30 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE